Emalex Biosciences Email Format
Biotechnology ResearchUnited States11-50 Employees
Emalex Biosciences is in late-stage development for a new class of drug for patients with Tourette syndrome and other neurological disorders.
| Emalex Biosciences Email Formats | Percentage |
| FLast@emalexbiosciences.com | 90% |
| First_Last@emalexbiosciences.com | 4% |
| First-Last@emalexbiosciences.com | 4% |
| First@emalexbiosciences.com | 2% |
Biotechnology ResearchUnited States11-50 Employees
Emalex Biosciences is in late-stage development for a new class of drug for patients with Tourette syndrome and other neurological disorders.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.